[Federal Register Volume 78, Number 54 (Wednesday, March 20, 2013)]
[Notices]
[Page 17231]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-06332]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application: 
Morton Grove Pharmaceuticals

    Pursuant to Sec.  1301.33(a), Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on December 14, 2012, Morton 
Grove Pharmaceuticals, 6451 Main Street, Morton Grove, Illinois 60053-
2633, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of Gamma 
Hydroxybutyric Acid (2010), a basic class of controlled substance 
listed in schedule I.
    The company plans to manufacture the listed controlled substance 
for distribution to its customers.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substance, may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than May 20, 2013.

    Dated: March 12, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2013-06332 Filed 3-19-13; 8:45 am]
BILLING CODE 4410-09-P